Use of the Naturally Occurring Bacteriophage Grouping Model for the Design of Potent Therapeutic Cocktails
-
Published:2024-04-24
Issue:5
Volume:13
Page:385
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Glonti Tea1ORCID, Goossens Michael1, Cochez Christel1, Green Sabrina2, Gorivale Sayali2, Wagemans Jeroen2ORCID, Lavigne Rob2ORCID, Pirnay Jean-Paul1ORCID
Affiliation:
1. Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, B-1120 Brussels, Belgium 2. Laboratory of Gene Technology, Department of Biosystems, KU Leuven, B-3001 Leuven, Belgium
Abstract
The specificity of phages and their ability to evolve and overcome bacterial resistance make them potentially useful as adjuncts in the treatment of antibiotic-resistant bacterial infections. The goal of this study was to mimic a natural grouping of phages of interest and to evaluate the nature of their proliferation dynamics with bacteria. We have, for the first time, transferred naturally occurring phage groups directly from their sources of isolation to in vitro and identified 13 P. aeruginosa and 11 K. pneumoniae phages of 18 different genera, whose host range was grouped as 1.2–17%, 28–48% and 60–87%, using a large collection of P. aeruginosa (n = 102) and K. pneumoniae (n = 155) strains carrying different virulence factors and phage binding receptors. We introduced the interpretation model curve for phage liquid culturing, which allows easy and quick analysis of bacterial and phage co-proliferation and growth of phage-resistant mutants (PRM) based on qualitative and partially quantitative evaluations. We assayed phage lytic activities both individually and in 14 different cocktails on planktonic bacterial cultures, including three resistotypes of P. aeruginosa (PAO1, PA14 and PA7) and seven K. pneumoniae strains of different capsular serotypes. Based on the results, the natural phage cocktails designed and tested in this study largely performed well and inhibited PRM growth either synergistically or in proto-cooperation. This study contributes to the knowledge of phage behavior in cocktails and the formulation of therapeutic phage preparations. The paper also provides a detailed description of the methods of working with phages.
Funder
Royal Higher Institute for Defense, Brussels, Belgium
Reference30 articles.
1. Haines, M.E.K., Hodges, F.E., Nale, J.Y., Mahony, J., van Sinderen, D., Kaczorowska, J., Alrashid, B., Akter, M., Brown, N., and Sauvageau, D. (2021). Analysis of Selection Methods to Develop Novel Phage Therapy Cocktails Against Antimicrobial Resistant Clinical Isolates of Bacteria. Front. Microbiol., 12. 2. WHO Regional Office for Europe/European Centre for Disease Prevention and Control (2024, April 17). Antimicrobial Resistance Surveillance in Europe 2022–2020 Data. Copenhagen: WHO Regional Office for Europe. Available online: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data. 3. European Centre for Disease Prevention and Control (2024, April 17). Surveillance of antimicrobial resistance in Europe 2018. Stockholm: ECDC. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2018.pdf. 4. Nikolich, M.P., and Filippov, A.A. (2020). Bacteriophage Therapy: Developments and Directions. Antibiotics, 9. 5. Pirnay, J.P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., and Green, S. (2023). Retrospective, observational analysis of the first one hundred consecutive cases of personalized bacteriophage therapy of difficult-to-treat infections facilitated by a Belgian consortium. medRxiv.
|
|